Obesity

Showing NaN - NaN of 117

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Coronary Artery Disease, Obesity Trial in Chicago, Omaha (Medium-intensity Minimally-directive Counseling)

Completed
  • Coronary Artery Disease
  • Obesity
  • Medium-intensity Minimally-directive Counseling
  • Chicago, Illinois
  • +1 more
Jul 20, 2020

Metabolism and Nutrition Disorder, Obesity Trial in Worldwide (Liraglutide 3.0 mg, Placebo)

Completed
  • Metabolism and Nutrition Disorder
  • Obesity
  • Liraglutide 3.0 mg
  • Placebo
  • Birmingham, Alabama
  • +53 more
Mar 13, 2020

Metabolism and Nutrition Disorder, Obesity Trial in United States (liraglutide, , CMS Intensive Behavior Therapy)

Completed
  • Metabolism and Nutrition Disorder
  • Obesity
  • Jacksonville, Florida
  • +9 more
Feb 28, 2020

Obesity Trial in United States (Aspiration Therapy (AspireAssist), Lifestyle Therapy)

Completed
  • Obesity
  • Aspiration Therapy (AspireAssist)
  • Lifestyle Therapy
  • San Diego, California
  • +9 more
Jan 23, 2020

Inflammation in Peritoneal Dialysis Patients: Effect of Obesity

Withdrawn
  • End-Stage Renal Disease
  • +3 more
    • Chicago, Illinois
      University of Illinois at Chicago
    Oct 28, 2019

    Pain, Obesity, Hypoxia Trial in Chicago (Ketamine, )

    Completed
    • Pain
    • +2 more
    • Chicago, Illinois
      Northwestern Memorial Hospital
    Oct 3, 2019

    Colon Inflammation, Iron Malabsorption, Obesity Trial in Chicago (High heme iron diet, Low iron diet, Plant-based high non-heme

    Completed
    • Colon Inflammation
    • +3 more
    • High heme iron diet
    • +2 more
    • Chicago, Illinois
      University of Illinois at Chicago
    Sep 25, 2019

    Obesity, Morbid Obesity, Diabetes, Type 2 Trial in Chicago (Intermittent Fasting)

    Unknown status
    • Obesity
    • +3 more
    • Intermittent Fasting
    • Chicago, Illinois
      The University of Chicago
    Sep 18, 2019

    Obesity Trial in United States (Leu Sil 1.0mg, Leu Sil 4.0mg, Leu Met Sil 1.0mg)

    Completed
    • Obesity
    • Leu Sil 1.0mg
    • +4 more
    • Mobile, Alabama
    • +14 more
    Aug 19, 2019

    Obesity Trial in Chicago (Small changes weight loss program)

    Completed
    • Obesity
    • Small changes weight loss program
    • Chicago, Illinois
      Rush University Medical Center
    Aug 15, 2019

    Obesity Trial in Chicago (Personalized exercise programme (PEP))

    Completed
    • Obesity
    • Personalized exercise programme (PEP)
    • Chicago, Illinois
      University of Illinois, Chicago
    Jul 24, 2019

    CRIC-Visceral Adiposity and Physical Fitness in Chronic Kidney

    Completed
    • Renal Insufficiency, Chronic
    • Obesity
      • Chicago, Illinois
      • +9 more
      Jul 19, 2019

      Cardiovascular Disease, High Cardiovascular Risk, Obesity Trial in Worldwide (Lorcaserin HCl, Placebo)

      Completed
      • Cardiovascular Disease
      • +4 more
      • Lorcaserin hydrochloride
      • Placebo
      • Alexander City, Alabama
      • +498 more
      Jun 27, 2019

      PreDiabetes, Obesity, Metabolic Disease Trial in Chicago (Promotora-led Intervention (PLI), Usual care (UC))

      Completed
      • PreDiabetes
      • +4 more
      • Promotora-led Intervention (PLI)
      • Usual care (UC)
      • Chicago, Illinois
        Northwestern Univeristy
      Jun 3, 2019

      Obesity Trial in Chicago (Acceptance Based Behavioral Intervention)

      Completed
      • Obesity
      • Acceptance Based Behavioral Intervention
      • Chicago, Illinois
        Rush University Medical Center
      Mar 26, 2019

      Endometrial Clear Cell Adenocarcinoma, Endometrial Serous Adenocarcinoma, Fatigue Trial in Korea, Republic of, United States

      Unknown status
      • Endometrial Clear Cell Adenocarcinoma
      • +6 more
      • 3-Dimensional Conformal Radiation Therapy
      • +7 more
      • Birmingham, Alabama
      • +539 more
      Mar 8, 2019

      Kidney Transplant; Complications, Liver Transplant; Complications, Obesity Trial in Chicago, Philadelphia (Self-monitoring of

      Completed
      • Kidney Transplant; Complications
      • +2 more
      • Self-monitoring of physical activity with incentives
      • Usual care and self-monitoring of physical activity
      • Chicago, Illinois
      • +1 more
      Feb 26, 2019

      A Post-approval LAP-BAND® Lower Body Mass Index (LBMI) Study

      Terminated
      • Obesity
      • Overweight
        • Fountain Valley, California
        • +10 more
        Jun 25, 2018

        Obesity Trial in United States (S-2367 Placebo, S-2367 1600 mg q.d. 54 Weeks, S-2367 1600 mg q.d. 60 weeks)

        Completed
        • Obesity
        • S-2367 Placebo
        • +4 more
        • Birmingham, Alabama
        • +39 more
        May 9, 2018

        Obesity Trial in United States (S-2367 Placebo, S-2367 800 mg, S-2367 1600 mg)

        Completed
        • Obesity
        • S-2367 Placebo
        • +3 more
        • Mobile, Alabama
        • +37 more
        May 8, 2018

        Obesity Trial in United States (S-2367 (velneperit))

        Completed
        • Obesity
        • S-2367 (velneperit)
        • Birmingham, Alabama
        • +72 more
        Apr 26, 2018

        Diabetes, Hyperglycemia, Obesity Trial in Chicago, Evanston (Standard Lifestyle Advice, Advice Plus Lifestyle Intervention)

        Completed
        • Diabetes Mellitus
        • +10 more
        • Standard Lifestyle Advice
        • Advice Plus Lifestyle Intervention
        • Chicago, Illinois
        • +1 more
        Mar 27, 2018

        Hyperglycemia, Obesity, Diabetes Trial in Chicago (Dietitian Counseling Alone, Dietitian Plus Community Group Lifestyle)

        Completed
        • Hyperglycemia
        • +2 more
        • Dietitian Counseling Alone
        • Dietitian Plus Community Group Lifestyle
        • Chicago, Illinois
          Northwestern University
        Mar 27, 2018

        Metabolism and Nutrition Disorder, Obesity Trial in Worldwide (liraglutide, )

        Completed
        • Metabolism and Nutrition Disorder
        • Obesity
        • Vestavia Hills, Alabama
        • +160 more
        Dec 6, 2017

        Metabolism and Nutrition Disorder, Obesity, Obstructive Sleep Apnoea Trial in Canada, United States (liraglutide, )

        Completed
        • Metabolism and Nutrition Disorder
        • +2 more
        • Glendale, California
        • +41 more
        Sep 29, 2017